BERTRAND L. JABER, MD
Osteopathic Medicine in Boston, MA
License number
Massachusetts 79205
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
11 Nevins St. SUITE 202, Boston, MA 02135
Phone
(617) 779-6700
(617) 779-6771 (Fax)
(617) 779-6771 (Fax)
Organization information
See more information about BERTRAND L. JABER at bizstanding.comSt Elizabeth's Medical Center - Gary T Robezen MD
736 Cambridge St, Brighton, MA 02135
Doing business as:
St Elizabeth's Medical Center - Bertrand L Jaber MD<br>St Elizabeth's Medical Center - Fahad Alotaibe MD<br>St Elizabeth's Medical Center - Curtis Cetrulo MD<br>St Elizabeth's Medical Center - Claudia P Garcia MD<br>St Elizabeth's Medical Center - Brian A Canavan MD<br>St Elizabeth's Medical Center - Carlos R Vassaux MD<br>St Elizabeth's Medical Center - Brian J Trainor Do
Site:
Phone:
(617) 789-3000 (Phone)
Categories:
Internal Medicine Physicians & Surgeons, Electronic Commerce, Nephrology Physicians & Surgeons, ...
Products:
Neurology, Neurosurgery, Oncology, ...
Steward Medical Group - Bertrand L Jaber MD
11 Nevins St STE 202, Brighton, MA 02135
Categories:
Nephrology Physicians & Surgeons
Site:
Phone:
(617) 779-6700 (Phone)
Professional information
Bertrand Lionel Jaber, Brighton MA
Specialties:
Internal Medicine, Nephrology, Pulmonary Disease
Work:
SMG Brighton Nephrology
11 Nevins St, Brighton, MA 02135 Caritas St. Elizabeth's Medical Center
736 Cambridge St, Brighton, MA 02135
11 Nevins St, Brighton, MA 02135 Caritas St. Elizabeth's Medical Center
736 Cambridge St, Brighton, MA 02135
Education:
Universite Saint-Joseph (1991)
Bertrand L Jaber, Brighton MA
Specialties:
Nephrologist
Address:
11 Nevins St, Brighton, MA 02135
736 Cambridge St, Brighton, MA 02135
736 Cambridge St, Brighton, MA 02135
Education:
Saint Joseph University, Faculty of Medicine - Doctor of Medicine*
Beth Israel Deaconess Medical Center - Fellowship - Clinical Neurophysiology (Neurology)*
Caritas Carney Hospital - Residency - Internal Medicine*
Beth Israel Deaconess Medical Center - Fellowship - Clinical Neurophysiology (Neurology)*
Caritas Carney Hospital - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)*
Dr. Bertrand L Jaber - MD (Doctor of Medicine)
Hospitals:
SMG Brighton Nephrology
11 Nevins St STE 202, Brighton 02135
Saint Elizabeth's Medical Center
736 Cambridge Street Ave, Brighton 02135
SMG Brighton Nephrology
11 Nevins St STE 202, Brighton 02135
Saint Elizabeth's Medical Center
736 Cambridge Street Ave, Brighton 02135
11 Nevins St STE 202, Brighton 02135
Saint Elizabeth's Medical Center
736 Cambridge Street Ave, Brighton 02135
SMG Brighton Nephrology
11 Nevins St STE 202, Brighton 02135
Saint Elizabeth's Medical Center
736 Cambridge Street Ave, Brighton 02135
Education:
Medical Schools
Faculte Francaise De Medecine Et De Pharmacie
Graduated: 1991
Faculte Francaise De Medecine Et De Pharmacie
Graduated: 1991
Method For Protecting Renal Tubular Epithelial Cells From Radiocontrast Nephropathy (Rcn)
US Patent:
2010000, Jan 7, 2010
Filed:
Dec 7, 2007
Appl. No.:
12/312932
Inventors:
Alexey Y. Kolyada - Newton MA, US
Bertrand L. Jaber - South Boston MA, US
Orfeas Liangos - Brighton MA, US
Nicolaos E. Madias - Newton MA, US
Bertrand L. Jaber - South Boston MA, US
Orfeas Liangos - Brighton MA, US
Nicolaos E. Madias - Newton MA, US
Assignee:
Caritas St. Elizabeth's Medical Center of Boston, Inc. - Boston MA
International Classification:
A61K 51/00, C12Q 1/02
US Classification:
424 165, 435 29
Abstract:
According to aspects of the invention, methods for preventing or treating kidney damage are provided. Compositions for the prevention or treatment of kidney damage are also provided. Aspects of the invention relate to methods for screening the toxicity of a radio-contrast agent. Kits for the treatment or prevention of kidney damage are also provided.
Method For Estimating Risk Of Acute Kidney Injury
US Patent:
2011005, Mar 10, 2011
Filed:
Sep 18, 2008
Appl. No.:
12/677393
Inventors:
Orfeas Liangos - Brighton MA, US
Francesco Addabbo - Valhalla NY, US
Michael Goligorsky - Valhalla NY, US
Bertrand L. Jaber - South Boston MA, US
Francesco Addabbo - Valhalla NY, US
Michael Goligorsky - Valhalla NY, US
Bertrand L. Jaber - South Boston MA, US
Assignee:
Caritas St. Elizabeth's Medical Center of Boston, Inc. - Boston MA
New York Medical College - Valhalla NY
New York Medical College - Valhalla NY
International Classification:
G01N 33/53
US Classification:
436 86
Abstract:
Methods and products for identifying subjects at risk of acute kidney injury (AKI) are provided according to the invention. Included, for instance, are diagnostic kits and methods involving the use of at least two AKI associated markers.
Method For Inhibiting Tnf-Alpha
US Patent:
2008023, Sep 25, 2008
Filed:
Jul 26, 2006
Appl. No.:
11/997484
Inventors:
Gregory Oxenkrug - Newton MA, US
Bertrand L. Jaber - South Boston MA, US
Mary C. Perianayagam - Reading MA, US
Bertrand L. Jaber - South Boston MA, US
Mary C. Perianayagam - Reading MA, US
Assignee:
CARITAS ST. ELIZABETH'S MEDICAL CENTER - BOSTON MA
International Classification:
A61K 31/165, C12N 5/06, A61P 19/00
US Classification:
514622, 435375
Abstract:
The present invention encompasses methods for inhibiting TNF-alpha expression with N-substituted dopamine derivatives. In this method a cell is administered a pharmaceutically effective amount of N-acetyl dopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating a cell, preferably in an animal or human suffering from overexpression or abundant TNF-alpha. The N-acetyldopamine derivative or N-alkyldopamine derivatives may be administered alone or in combination with N-acetylserotonin (NAS) or other compound to inhibit TNF-alpha expression. Also disclosed is a method of treating a TNF-alpha related disease and/or disorder using such a compound.